Search for a clinical study
Alnylam ALN-APP-001: Phase I, Placebo-Controlled Trial of ALN-APP in Participants with Early-Onset Alzheimer’S Disease
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of ...
1011003300 National Cell Repository for Alzheimer's Disease
Does more than one member of your family have Alzheimer’s disease or serious memory loss? Your family can be an essential part of Alzheimer's disease research by participating in the ...
1011003338 Indiana Alzheimer Disease Core Center
The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer's disease, those who have other disorders of memory and thinking, and older individuals who ...
Parkinson's Progression Markers Initiative 2.0 Remote Study
The purpose of PPMI 2.0 Remote is to find out if information collected remotely (by internet, mail, home visits, or phone applications) can help identify individuals at an increased risk ...
The Assessment of Smart Phone Everyday Tasks (ASSET): a New IADL Test for Early AD
The overall goal of this project is to validate a novel performance-based IADL instrument that uses a smartphone to assess healthcare-related daily activities, ASSET. This IADL test has been designed ...
Join Us in Advancing Alzheimer’S Research—Your Blood Sample Can Make a Difference
One Blood Sample. One Visit. A Big Impact.The Indiana Biobank is a research program that began in 2010 through the Indiana University School of Medicine and IU Health. You can ...
Autosomal Dominant Osteopetrosis: a Natural History Study
?Physicians at Indiana University want to learn more about Osteopetrosis, especially Autosomal Dominant Osteopetrosis. Osteopetrosis is a rare metabolic bone disease that can cause hard bones that can break easily. Not enough ...
Nicotinic Acid for the Treatment of Alzheimer's Disease Protocol Type: Interventional
The primary objective of this study is to collect data on the penetration of commercially available, FDA approved, extended-release niacin into the spinal fluid. One dose of 500 mg nicotinic ...
The ADRC Consortium for Clarity in ADRD Research Through Imaging
This study seeks to identify the several possible causes of dementia that may be present in an individual, and that may be contributing to a person’s current or future cognitive ...
Multi-Modal Large Language Model-Empowered Talk Therapy for Older Adults with Adrd
The purpose of this study is to test the usefulness and the effect of the Smart Virtual Reminiscence (SVR) therapy intervention on the Behavioral and Psychological Symptoms of Dementia (BPSD) of ...